LPL Financial
CTXR icon

LPL Financial’s Citius Pharmaceuticals CTXR Stock Holding History

LPL Financial’s Portfolio CTXR Stock Details CTXR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.4K Buy
25,445
+400
+2% +$271 ﹤0.01% 6141
2026
Q1 		$22.5K Sell
25,045
-22
-0.1% -$18 ﹤0.01% 5867
2025
Q4 		$19.5K Buy
+25,067
New +$31.3K ﹤0.01% 5809
2024
Q4 		– Sell
-459
Closed -$5.75K – 5316
2024
Q3 		$5.75K Sell
459
-2,000
-81% -$33.7K ﹤0.01% 5144
2024
Q2 		$35.9K Buy
2,459
+120
+5% +$2.15K ﹤0.01% 4881
2024
Q1 		$52.5K Buy
2,339
+5
+0.2% +$91 ﹤0.01% 4761
2023
Q4 		$44.1K Buy
+2,334
New +$44.3K ﹤0.01% 4665
2022
Q2 		– Sell
-898
Closed -$40K – 4445
2022
Q1 		$40K Buy
898
+28
+3% +$1.11K ﹤0.01% 4075
2021
Q4 		$33K Buy
870
+4
+0.5% +$181 ﹤0.01% 4262
2021
Q3 		$44K Buy
+866
New +$43.4K ﹤0.01% 4237

Other funds holding CTXR

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
MFS
Miller Financial Services Marshall, Michigan $124M AUM 17.62% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
AAG
Asset Advisory Group Kinnelon, New Jersey $229M AUM

LPL Financial's CTXR Position: Q2 2026 in Review

LPL Financial increased its Citius Pharmaceuticals (CTXR) stake by 1.6% in Q2 2026, buying an estimated $271 and bringing the position to 25,445 shares worth $15.4K. The position accounts for ﹤0.01% of the portfolio, ranked #6141.

LPL Financial first reported a position in CTXR in Q3 2021 and has held it in 10 quarters since. The position peaked at $52.5K in Q1 2024. 43 funds tracked by Wall St. Rank hold CTXR as of Q2 2026.

  • LPL Financial held 25,445 shares of Citius Pharmaceuticals worth $15.4K as of Q2 2026.
  • LPL Financial bought 400 Citius Pharmaceuticals shares in Q2 2026, an estimated $271.
  • Citius Pharmaceuticals made up ﹤0.01% of LPL Financial's portfolio in Q2 2026, its #6141 holding.
  • LPL Financial first reported a position in Citius Pharmaceuticals in Q3 2021 and has held it in 10 quarters since.
  • LPL Financial's Citius Pharmaceuticals position peaked at $52.5K in Q1 2024.
  • 43 funds tracked by Wall St. Rank held Citius Pharmaceuticals as of Q2 2026.

Based on LPL Financial's 13F filing for Q2 2026, filed 7 Aug 2026.